in ,

Johnson & Johnson and AstraZeneca companies continue Covid-19 vaccine studies

Johnson & Johnson and AstraZeneca companies in the USA to continue their Covid-19 vaccine studies. It stated that the American pharmaceutical manufacturer Johnson and Johnson (JJ), which stopped the new type of Coronavirus (Covid-19) vaccine trials in the USA a while ago, and AstraZeneca companies will continue their work.

It noted that the US Food and Drug Administration (FDA) gave the green light to both companies to continue their vaccine trials.

AstraZeneca CEO Pascal Soriot said: “The relaunch of clinical trials around the world is great news, because we need to continue our efforts to develop this vaccine to help defeat this terrible pandemic. ”

Phase 2 vaccine trials conducted by AstraZeneca company with Oxford University against Covid-19 virus. On September 6, work in the USA suspended due to a neurological problem in one of the subjects.

In addition to cosmetic and hygienic products, medical equipment and drug manufacturers Johnson and Johnson will be on October 12. Covid-19 announced that a participant in vaccine trials suspended due to illness. Johnson and Johnson signed a $ 1 billion deal with the US government for the production and delivery of 100 million doses of Covid-19 vaccine on August 5.

Written by Maraaz

Emilia Clarke from theater to Hollywood star

Visit from Bolsonaro to the minister who was infected with the coronavirus without a mask